Special Issue "Recent Advances in Biotechnology"
Deadline for manuscript submissions: closed (31 December 2020).
Interests: cancer immunology; cell death execution pathways; cancer stem cell biology; epigenetic reprogramming (production of iPS-cells); transdifferentiation technologies; other aspects of regenerative pharmacology
Special Issues and Collections in MDPI journals
The 21st century is witnessing a rapid progress in biotechnology that will likely revolutionize medical interventions not only in the area of transplantology but also in that of drug delivery, with the identification of the most suitable cell subpopulations as primary therapeutic targets in oncology and in tissue regeneration. For example, in 2006 Yamanaka and colleagues developed a technology to produce isogenic (embryonic-like) induced pluripotent stem cells (iPSCs) from somatic cells by the process of reprogramming. iPSCs could then be differentiated into virtually any cell type in the body. In the meantime, an alternative technology of customized cell production from somatic cells through the process of transdifferentiation has progressed. Furthermore, our understanding of the biology of cancer allows for pinpointing cell populations (cancer stem cells, cancer initiating cells, cancer propagating cells) that are responsible for therapeutic failure. On the other hand, in the material science area, new composite materials (biodegradable and non-biodegradable) are being developed that may replace specific components of the connective tissue in different specialized organs. The proposed Special Issue aims to present diverse advances in biotechnology (i) at the level of cell and tissue engineering, (ii) at the level of advanced cancer therapy development, and (iii) at the level of biomaterial and general biotechnology science. Hence, it aims to bridge the gap between the above-mentioned research areas, while presenting specific aspects in an understandable manner to researchers from distinct research fields.
Prof. Dr. Marek J. Łos
Dr. Artur Cieślar-Pobuda
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- stem cells
- tissue engineering
- 3D printing